Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment
We herein present behavioral data on whether memantine, an adamantane derivative and medical NMDA-receptor antagonist, improves spatial and latent learning deficits in amyloid precursor protein/presenilin 2 double-transgenic mice (PS2Tg2576 mice). In PS2Tg2576 mice, early amyloid-β protein (Aβ) depo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Data in Brief |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340921004157 |
id |
doaj-2130f2ff20024b6480d8746302a9b50f |
---|---|
record_format |
Article |
spelling |
doaj-2130f2ff20024b6480d8746302a9b50f2021-06-27T04:38:28ZengElsevierData in Brief2352-34092021-06-0136107131Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatmentMasahisa Matsumura0Kana Sato1Takashi Kubota2Yasushi Kishimoto3Laboratory of Neurobiophysics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri UniversityLaboratory of Neurobiophysics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri UniversityLaboratory of Neurobiophysics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri UniversityLaboratory of Neurobiophysics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University; Laboratory of Physical Chemistry, Faculty of Pharma-Science, Teikyo University; Corresponding author.We herein present behavioral data on whether memantine, an adamantane derivative and medical NMDA-receptor antagonist, improves spatial and latent learning deficits in amyloid precursor protein/presenilin 2 double-transgenic mice (PS2Tg2576 mice). In PS2Tg2576 mice, early amyloid-β protein (Aβ) deposition at 2–3 months of age and progressive accumulation at about 5 months of age has been shown. Thus, PS2Tg2576 mice were subjected to Morris water maze (MWM) test for spatial memory and the water-finding test for latent memory testing at ages 3 and 5–6 months. In addition, memantine (30 mg/kg/day, p.o.) was administered 3–4 weeks before commencing the behavioral tasks to check for effects on cognitive function. The information provided in this paper adds to the literature and can be used for the selection of animal models and behavioral paradigms for Alzheimer's disease (AD) research.http://www.sciencedirect.com/science/article/pii/S2352340921004157Alzheimer's diseaseLatent memoryMemantinePresenilin 2Spatial memory |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Masahisa Matsumura Kana Sato Takashi Kubota Yasushi Kishimoto |
spellingShingle |
Masahisa Matsumura Kana Sato Takashi Kubota Yasushi Kishimoto Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment Data in Brief Alzheimer's disease Latent memory Memantine Presenilin 2 Spatial memory |
author_facet |
Masahisa Matsumura Kana Sato Takashi Kubota Yasushi Kishimoto |
author_sort |
Masahisa Matsumura |
title |
Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment |
title_short |
Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment |
title_full |
Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment |
title_fullStr |
Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment |
title_full_unstemmed |
Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment |
title_sort |
spatial and latent memory data in ps2tg2576 alzheimer's disease mouse model after memantine treatment |
publisher |
Elsevier |
series |
Data in Brief |
issn |
2352-3409 |
publishDate |
2021-06-01 |
description |
We herein present behavioral data on whether memantine, an adamantane derivative and medical NMDA-receptor antagonist, improves spatial and latent learning deficits in amyloid precursor protein/presenilin 2 double-transgenic mice (PS2Tg2576 mice). In PS2Tg2576 mice, early amyloid-β protein (Aβ) deposition at 2–3 months of age and progressive accumulation at about 5 months of age has been shown. Thus, PS2Tg2576 mice were subjected to Morris water maze (MWM) test for spatial memory and the water-finding test for latent memory testing at ages 3 and 5–6 months. In addition, memantine (30 mg/kg/day, p.o.) was administered 3–4 weeks before commencing the behavioral tasks to check for effects on cognitive function. The information provided in this paper adds to the literature and can be used for the selection of animal models and behavioral paradigms for Alzheimer's disease (AD) research. |
topic |
Alzheimer's disease Latent memory Memantine Presenilin 2 Spatial memory |
url |
http://www.sciencedirect.com/science/article/pii/S2352340921004157 |
work_keys_str_mv |
AT masahisamatsumura spatialandlatentmemorydatainps2tg2576alzheimersdiseasemousemodelaftermemantinetreatment AT kanasato spatialandlatentmemorydatainps2tg2576alzheimersdiseasemousemodelaftermemantinetreatment AT takashikubota spatialandlatentmemorydatainps2tg2576alzheimersdiseasemousemodelaftermemantinetreatment AT yasushikishimoto spatialandlatentmemorydatainps2tg2576alzheimersdiseasemousemodelaftermemantinetreatment |
_version_ |
1721358480536764416 |